Monday, December 01, 2008
 
 
  Home arrow Birth Control arrow Research & Statistics arrow Estrogen Linked to Breast Cancer (2007)
Main Menu
Home
About Us
Current Headlines
Abortion
Abstinence
Birth Control
End of Life / Euthanasia
Medical Research
Medical Students
Population
Position Statements
Pregnancy/Development
STDs
Stem Cells & Cloning
Contact Us
Web Links
Site Index
Resources
Related Items
Translator
Quotes to Note
“…Congress found…that this method of killing a living fetus- performed on fetuses that are at or near viability-…perverts the birth process, blurs the line between abortion and infanticide, and confuses the medical, legal, and ethical duties of physicians to preserve life. Congress also found that partial-birth abortion imposes severe pain on the fetus.” “Congress specifically found that partial-birth abortion poses serious risks of its own to the health of a woman undergoing the procedure. Those risks include…cervical incompetence, potentially hindering a woman’s ability to carry a subsequent pregnancy to term, and a risk of lacerations and severe hemorrhaging from a doctor forcing a sharp instrument into the base of the skull of the fetus while it is lodged in the birth canal. Additional risks include that of uterine rupture, abruption, amniotic fluid embolus, and trauma to the uterus as a result of any conversion of the fetus to a footling breech position...” [Excerpts from previous Department of Justice filings from spokesman Monica Goodling, who published a detailed explanation of the legal issues involved in the Partial-Birth Abortion Ban case]
 
Estrogen Linked to Breast Cancer (2007) PDF Print E-mail

The female sex hormone estrogen turns on a gene linked to breast cancer, according to new research by Brisbane scientists.

The cancer biology team from UQ's Diamantina Institute for Cancer, Immunology and Metabolic Medicine, believe their finding will help explain the link between breast cancer and high levels of estrogen.

“What we've shown is that the ability of estrogen to switch this gene on is important for the growth of breast cancer cells,” Diamantina cancer biology research leader Professor Tom Gonda said.

The gene they studied, known as MYB, is found in about 70 percent of all breast cancers and is one of several dozen genes called oncogenes that promote cancer growth.

“What's important in breast cancer is the ability of estrogen to turn on MYB rather than there being a mutation in the gene itself,” Professor Gonda said.

He said the next step was to take the results, which come from isolated cancer cells grown in the laboratory, and test them in laboratory mice that are a better model for human patients.

“We're trying to show directly that MYB can induce cancerous changes in normal breast cells.”

Professor Gonda and his colleagues at UQ worked with researchers in Melbourne, Adelaide and the United States and published their findings this month in the prestigious scientific journal Proceedings of the National Academy of Sciences of the USA.

He said a drug that blocks the action of MYB might be used to treat breast cancer in the future but he warned that would take many years of hard work.
[ 23 August 2007, University of Queensland]

The original press release can be found at http://www.uq.edu.au/news/index.html?article=12773 (publ. 22 Aug 2007)


[Excerpts]:

The female sex hormone estrogen turns on a gene linked to breast cancer, according to new research by Brisbane scientists. 

The cancer biology team from UQ's Diamantina Institute for Cancer, Immunology and Metabolic Medicine, believe their finding will help explain the link between breast cancer and high levels of estrogen.

The gene the group studied, known as MYB, is found in about 70 percent of all breast cancers and is one of several dozen genes called oncogenes that promote cancer growth.

Professor Gonda and his colleagues at UQ worked with researchers in Melbourne, Adelaide and the United States and published their findings this month in the prestigious scientific journal Proceedings of the National Academy of Sciences of the USA.

He said a drug that blocks the action of MYB might be used to treat breast cancer in the future but he warned that would take many years of hard work.
 
< Prev   Next >


Go to top of page  Home | About Us | Current Headlines | Abortion | Abstinence | Birth Control | End of Life / Euthanasia | Medical Research | Medical Students | Population | Position Statements | Pregnancy/Development | STDs | Stem Cells & Cloning | Contact Us | Web Links | Site Index | Resources |
 
PhysiciansForLife.org Copyright (C) 2004-2008 All Rights Reserved